Inositol monophosphatase inhibitor : Lithium mimetics?ATACK, J. R.Medicinal research reviews (Print). 1997, Vol 17, Num 2, pp 215-224, issn 0198-6325Article

Cerebrospinal fluid Inositol monophosphatase : Elevated activity in depression and neuroleptic-treated schizophreniaATACK, J. R; LEVINE, J; BELMAKER, R. H et al.Biological psychiatry (1969). 1998, Vol 44, Num 6, pp 433-437, issn 0006-3223Article

Structure of inositol monophosphatase, the putative target of lithium therapyBONE, R; SPRINGER, J. P; ATACK, J. R et al.Proceedings of the National Academy of Sciences of the United States of America. 1992, Vol 89, Num 21, pp 10031-10035, issn 0027-8424Article

Decreased CSF inositol monophosphatase activity after lithium treatmentMOLCHAN, S. E; ATACK, J. R; SUNDERLAND, T et al.Psychiatry research. 1994, Vol 53, Num 1, pp 103-105, issn 0165-1781Article

Neural tube defect-specific acetylcholinesterase: its properties and quantitation in the detection of anencephaly and spina bifidaBONHAM, J. R; DALE, G; ATACK, J. R et al.Clinica chimica acta. 1987, Vol 170, Num 1, pp 69-77, issn 0009-8981Article

A neural tube defect specific form of acetylcholinesterase in amniotic fluidBONHAM, J. R; ATACK, J. R.Clinica chimica acta. 1983, Vol 135, Num 2, pp 233-237, issn 0009-8981Article

Characterization of [³⁵S]t -butylbicyclophos phorothionate ([³⁵S]TBPS) binding to GABA_A receptors in postmortem human brainATACK, J. R; OHASHI, Y; MCKERNAN, R. M et al.British journal of pharmacology. 2007, Vol 150, Num 8, pp 1066-1074, issn 0007-1188, 9 p.Article

Characterization of inositol monophosphatase in human cerebrospinal fluidATACK, J. R; RAPOPORT, S. I; VARLEY, C. L et al.Brain research. 1993, Vol 613, Num 2, pp 305-308, issn 0006-8993Article

Inositol monophosphatase : a putative target for Li⁺ in the treatment of bipolar disorderATACK, J. R; BROUGHTON, H. B; POLLACK, S. J et al.Trends in neurosciences (Regular edition). 1995, Vol 18, Num 8, pp 343-349, issn 0166-2236Article

Immunohistochemical localization of intracellular plasma proteins in the human central nervous systemLIU, H. M; ATACK, J. R; RAPOPORT, S. I et al.Acta neuropathologica. 1989, Vol 78, Num 1, pp 16-21, issn 0001-6322Article

Regional analysis of rat brain proteins during senescenceCOSGROVE, J. W; ATACK, J. R; RAPOPORT, S. I et al.Experimental gerontology. 1987, Vol 22, Num 3, pp 187-198, issn 0531-5565Article

Changes in [³H]zolpidem and [³H]Ro 15-1788 binding in rat globus pallidus and substantia nigra pars reticulata following a nigrostriatal tract lesionCHADHA, A; HOWELL, O; ATACK, J. R et al.Brain research. 2000, Vol 862, Num 1-2, pp 280-283, issn 0006-8993Article

Characterization of the effects of lithium on phosphatidylinositol (PI) cycle activity in human muscarinic m1 receptor-transfected CHO cellsATACK, J. R; PRIOR, A. M; GRIFFITH, D et al.British journal of pharmacology. 1993, Vol 110, Num 2, pp 809-815, issn 0007-1188Article

Preclinical and clinical pharmacology of TPA023 B, a GABA_A receptor α2/α3 subtype-selective partial agonistATACK, J. R; HALLETT, D. J; CARLING, R. W et al.Journal of psychopharmacology (Oxford). 2011, Vol 25, Num 3, pp 329-344, issn 0269-8811, 16 p.Article

An inverse agonist selective for α5 subunit-containing GABA_A receptors improves encoding and recall but not consolidation in the Morris water mazeCOLLINSON, N; ATACK, J. R; LAUGHTON, P et al.Psychopharmacologia. 2006, Vol 188, Num 4, pp 619-628, issn 0033-3158, 10 p.Article

Autoradiographic localization of α5 subunit-containing GABA_A receptors in rat brainSUR, C; FRESU, L; HOWELL, O et al.Brain research. 1999, Vol 822, Num 1-2, pp 265-270, issn 0006-8993Article

Probing the role of metal ions in the mechanism of inositol monophosphatase by site-directed mutagenesisPOLLACK, S. J; KNOWLES, M. R; ATACK, J. R et al.European journal of biochemistry (Print). 1993, Vol 217, Num 1, pp 281-287, issn 0014-2956Article

CSF galanin and neuropeptide Y immunoreactivity in progressive supranuclear palsyLITVAN, I; BERRETTINI, W. H; ATACK, J. R et al.Acta neurologica scandinavica. 1992, Vol 86, Num 2, pp 204-206, issn 0001-6314Article

Carbamate analogues of (-)-physostigmine: in vivo inhibition of acetyl- and butyrylcholinesteraseQIAN-SHENG YU; ATACK, J. R; RAPOPORT, S. I et al.FEBS letters. 1988, Vol 234, Num 1, pp 127-130, issn 0014-5793Article

Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous systemATACK, J. R; PERRY, E. K; BONHAM, J. R et al.Journal of neurochemistry. 1986, Vol 47, Num 1, pp 263-277, issn 0022-3042Article

GABA_A α1 subunit knock-out mice do not show a hyperlocomotor response following amphetamine or cocaine treatmentREYNOLDS, D. S; O'MEARA, G. F; NEWMAN, R. J et al.Neuropharmacology. 2003, Vol 44, Num 2, pp 190-198, issn 0028-3908, 9 p.Article

Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypesGRIMWOOD, S; LE BOURDELLES, B; RAGAN, C. I et al.Journal of neurochemistry. 1996, Vol 66, Num 6, pp 2239-2247, issn 0022-3042Article

Pharmacological evaluation of the cholinergic system in progressive supranuclear palsyLITVAN, I; BLESA, R; CLARK, K et al.Annals of neurology. 1994, Vol 36, Num 1, pp 55-61, issn 0364-5134Article

Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's diseaseKAYE, J. A; MAY, C; ATACK, J. R et al.Annals of neurology. 1988, Vol 24, Num 5, pp 647-650, issn 0364-5134Article

CSF and serum concentrations of albumin and IgG in Alzheimer's diseaseKAY, A. D; MAY, C; PAPADOPOULOS, N. M et al.Neurobiology of aging. 1987, Vol 8, Num 1, pp 21-25, issn 0197-4580Article